Search results for "zola"
showing 10 items of 271 documents
CCDC 1047964: Experimental Crystal Structure Determination
2015
Related Article: Wdeson P. Barros, M. Luisa Calatayud, Francesc Lloret, Miguel Julve, Nadia Marino, Giovanni De Munno, Humberto O. Stumpf, Rafael Ruiz-García, Isabel Castro|2016|CrystEngComm|18|437|doi:10.1039/C5CE02058A
CCDC 240640: Experimental Crystal Structure Determination
2005
Related Article: C.Miranda, F.Escarti, L.Lamarque, E.Garcia-Espana, P.Navarro, J.Latorre, F.Lloret, H.R.Jimenez, M.J.R.Yunta|2005|Eur.J.Inorg.Chem.||189|doi:10.1002/ejic.200400671
CCDC 927862: Experimental Crystal Structure Determination
2013
Related Article: Walter Cañon-Mancisidor, Carlos J. Gómez-García, Guillermo Mínguez Espallargas, Andres Vega, Evgenia Spodine, Diego Venegas-Yazigi, Eugenio Coronado|2014|Chemical Science|5|324|doi:10.1039/C3SC52628C
Iron( ii ) and cobalt( ii ) complexes based on anionic phenanthroline-imidazolate ligands: reversible single-crystal-to-single-crystal transformations
2018
A series of low-spin FeII and CoII complexes based on phenanthroline-imidazolate (PIMP) ligands are reported. The FeII complex (H9O4)[Fe(PIMP)3]·(C4H10O)2(H2O) (1a) shows reversible crystalline phase transformations to afford two new phases (H9O4)[Fe(PIMP)3]·(H2O) (1b) and (H9O4)[Fe(PIMP)3]·(C8H18O)(C4H10O)(H2O) (1c) by release of diethyl ether and absorption of diethyl/dibutyl ether, respectively. This reversible uptake/release of solvent molecules is a clear example of single-crystal-to-single-crystal transformation involving a discrete metal complex. On the other hand, the corresponding CoII complex (H9O4)[Co(PIMP)3]·(C4H10O)2(H2O)2 (2) does not exhibit similar phase transformations. In …
Taste Disturbance with Acetazolamide
1997
Intranasal midazolam for treating acute respiratory crises in a woman with stiff person syndrome.
2020
Stiff person syndrome (SPS) is a rare neurologic disorder characterized by progressively worsening rigidity and spasms of the axial and limb muscles. Dyspnea has been recently recognized as a common symptom in SPS,1 and life-threatening respiratory crises have been occasionally reported and suspected to be responsible for sudden death in these patients.2,3 The pathophysiologic mechanisms of these respiratory manifestations remain unclear. Some authors have hypothesized that rigidity and/or spasm of the muscles of the trunk could prevent normal rib cage movements and excursion of the diaphragm.1
CCDC 1912382: Experimental Crystal Structure Determination
2019
Related Article: Javier Pitarch-Jarque, Kari Rissanen, Santiago García-Granda, Alberto Lopera, M. Paz Clares, Enrique García-España, Salvador Blasco|2019|New J.Chem.|43|18915|doi:10.1039/C9NJ05231C
Low-temperature optical spectroscopy of cobalt in Cu,Co superoxide dismutase: a structural dynamics study of the solvent-unaccessible metal site.
1995
The temperature dependence (300 to 10 K) of the electronic absorption spectra of the cobalt chromophore in bovine superoxide dismutase (SOD) having the native Zn(II) ion selectivity replaced by Co(II) has been investigated in four different derivatives: Cu(II),Co(II) SOD, N3(-)-Cu(II), Co(II) SOD, Cu(I),Co(II) SOD, and E,Co(II) SOD in which the copper ion has been selectively removed. In the Cu(II),Co(II) SOD, the cobalt spectrum is characterized at room temperature by three bands centered at 18,472, 17,670, and 16,793 cm-1; the low-frequency band is split, at low temperatures, into two components, indicating a lower symmetry contribution to a predominantly tetrahedral crystal field. Additi…
Center differences and cross-national invariance in help-seeking for panic disorder. A report from the cross-national collaborative panic study.
1992
Help-seeking behaviour for treatment of panic disorder was investigated in the sample of the Cross-National Collaborative Panic Study Second Phase. A total of 1168 patients were entered into this trial in 14 countries. Although there were significant center differences in prior treatment and utilization of health services there were also similarities. Treatment had been provided mainly by general practitioners. Drug treatment consisted mostly of prescription of classical tranquilizers and had a longer duration than treatment by psychotherapy. Patients with agoraphobic avoidance, past major depression and longer duration of illness used medical and psychiatric treatment facilities more inten…
Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo
1994
Summary Side effects play a significant role in the selection of drugs to be used in panic disorder/agoraphobia whose polyphobic symptomatology often includes a suspiciousness about taking drugs and a fear of undesired side effects which may lead to the refusal of treatment. The safety, side effects and patients' acceptance of alprazolam and imipramine versus placebo were evaluated in 1168 subjects with panic disorder/agoraphobia who had been enrolled in the second phase of the Upjohn World Wide Panic Study. Side effects that worsened over baseline to a greater extent with alprazolam than with imipramine and placebo were sedation, fatigue/weakness, memory problems, ataxia and slurred speech…